FL has received lecture honoraria, consultancy fees, or travel support from Amgen, Art Tempi, Astellas, AstraZeneca, Beigene, BioNTech AG, Bristol Myers Squibb, Daichi Sankyo, Elsevier, Incyte, Lilly, Medscape, Medupdate GmbH, Merck KGaA, Merck, Sharpe and Dohme, Roche, Servier, Streamedup!, and Zymeworks. RO has received lecture honoraria, consultancy fees, or travel support from BMS, Merck KGaA, and Servier. ECS has received lecture honoraria, consultancy fees, or travel support from AMAL Therapeutics, Astra Zeneca, Astellas, Beigene, BMS, Celgene, Elsevier, Everest Clinical Research, Five Prime Therapeutics, Gritstone Oncology, Novartis, Pfizer, Roche, Servier, and Zymeworks